Company Profile of Shenzhen Wahyong Analysis Instrument Co., Ltd.

Shenzhen Wahyong Analysis Instrument Co., Ltd. It was established in 2017 and is a comprehensive evaluation supplier for in vitro dissolution of drug formulations. It has been focusing on the research and development, production, and sales of drug dissolution systems, aiming to provide customers with one-stop solutions for in vitro dissolution. Wahyong Instrument adheres to the quality policy of "adhering to product development technology first", relying on well-known domestic and foreign university research platforms and senior technical experts with more than ten years of industry application experience, absorbing the latest research results of domestic and foreign dissolution instruments and continuously innovating, and meticulously creating multiple dissolution series products. At present, the company has over 50 independent intellectual property rights, including invention patents, utility model patents, appearance patents, and software copyrights. All series of products of Wahyong Instrument comply with regulations and standards such as USP, CHP, EP, JP, etc., and the software design meets the requirements of electronic records and audit tracking. The product manufacturing process has passed ISO9001 quality management system certification, and the product quality has passed CE certification. The products cover fully automatic sampling and dissolution instruments, reciprocating cylinder method dissolution instruments, flow cell method dissolution instruments, transdermal diffusion systems, online solvent degassers, etc. Wahyong Instrument currently cooperates with China Pharmaceutical University, Shenyang Pharmaceutical University, Tianjin University of Traditional Chinese Medicine, Shenzhen Technology University, Sun Yat-sen University School of Pharmaceutical Science (Shenzhen), Shandong University Zibo Biomedicine Research&Development Institute, Shandong Inomic Institute of Pharmaceutical Research , Guangzhou Novaken, Zhitong Laboratories, Huize Biopharma, Beijing Minkang Baicao, Beijing Novelpharm, Chengdu Yilukang, and Zhejiang East-Asia Pharmaceutical Fifteen universities and pharmaceutical companies have established joint R&D laboratories, covering five major regions in the China. Wahyong has contributed new strength to the development of China's pharmaceutical industry through the industry-university-research joint platform.